{"name":"City Therapeutics","slug":"city-therapeutics","ticker":"","exchange":"","domain":"","description":"City Therapeutics is a biotechnology company focused on developing innovative treatments for patients with unmet medical needs. The company's lead candidate, CITY-FXI, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSTgtMGFETmJJLTB6b2xfamtxUmJSQUdpTDI2aWFSZDBob1lWS0h0b05qNWxSSEV1Nmg4V2xKLXhOV3FGOThNamlXTnFUUzVTQmt6NlgyR1hNLVVGcVFKZ2phRHN2cjhDN2Rsb0VBT2FjSW5tbUlGWVBPSUgyZV9SazNNeTJqUk1ZUmxjNi1CR3l1SWVLaXNEd2ZKUHRXR0ZxSk5KUTM3TjNGUWx6dVFJejJieml4YU1mRXdXeDd0UGx5UQ?oc=5","date":"2026-04-03","type":"pipeline","source":"National Today","summary":"Terns Pharmaceuticals Grants Inducement Shares to New Employees - National Today","headline":"Terns Pharmaceuticals Grants Inducement Shares to New Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQOE1wZlRRVVEzSWZBcFprVTFEc1lLUFlyeTd1azRhNnlWdTlsQUZqT2M4RlRqOWRDcUNCQ2Q2T25sNVBBQk1WSmh4c0RFLVJvNVh3SDlzd2xLa1AwRmFQbFRqamhUZ0p3VTFTYmtYNUFjRVlVcnRGWW50TWR3NFRReGRjcDBCbXJMZTRmbENwUmYyZFY4MUJzY3NXMFVWYjhuaDB1a09mY21xX2VnMnI2RFUzYjVRTzBiM3c1YnZVc3JGZw?oc=5","date":"2026-02-19","type":"patent","source":"Business Wire","summary":"Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals - Business Wire","headline":"Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQXzlmZ3YySmdDWnMwNUNMckFlN1d1aENVcHl0S1h4eTR1MGJ3clNkYUtycHNZTXV3c2EtQ2l3eXh6VHJLQVBJNndQMWVaYmpCNzhNSWpBZGdSc1Vzdl9TV1hSanA4ZVZpVU1rbmwyOHY3a1JLQ0RWTUM1V1BDbDZ6MDdYbkUwc29sTlBjcmtpUEhWZTdYSjJuQmtNM2MwQzhLSy1VeEE5SktHNG1ic0FULXN3LWNtWmdCdXhrWWd4QmNXVVk?oc=5","date":"2025-12-02","type":"pipeline","source":"Pharmaceutical Technology","summary":"In a Honduran city, biotechs create gene therapy cocktails to fight aging - Pharmaceutical Technology","headline":"In a Honduran city, biotechs create gene therapy cocktails to fight aging","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPZnRIVk9ocXV5clNjTzhMeW4xQVZFUTFkbHZrSnM1RDZQcmFTYmxjV3ZDeWIxQndaWmtvdnhYX3dDblZhNEtJYUtqbkV6MVdIX3YyeXNYMldZd0pSMXhzbnM4cXV3cjNZWFhQNDlfM2hZbUZ1ZzA2WEZqT2dzNXZyMzJoWWxuejY5aTZoNjB1cl9QX0JPUDV2TEcxU3Rncjg?oc=5","date":"2025-09-02","type":"pipeline","source":"MedCity News","summary":"Novartis Tries Again in Parkinson’s, Putting Up $200M for Arrowhead’s RNAi Therapy - MedCity News","headline":"Novartis Tries Again in Parkinson’s, Putting Up $200M for Arrowhead’s RNAi Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPVkFGaFhRTlR6ZVVsYWxyaEZxS0NNSzJYZ24tc1VMeFZHc2puUmU0VGNjczFURW1FX2FwYVV1NUlmNmZDYVB0bktscXY5TEJhVWthcmhveTVHcmZtN0RtLWJ0cFFDTDAwcjFWT0ZUSzdkMDluZFJtVklaRkNUUjI2bGxCTQ?oc=5","date":"2025-07-10","type":"pipeline","source":"WHYY","summary":"Layoffs hit Philly biotech startup after being bought by Big Pharma - WHYY","headline":"Layoffs hit Philly biotech startup after being bought by Big Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNR19zTmNNVGZBdFRDbUxrM1loU0xGSDNYNUJuS0ZZT3JYZHZpalRweFNTbkl1WU9VQVBjRHg3ZWk2VWYyb0dYYmloTWVLeFVKNUhmVng4dGRWR0hBb3FoSEZQQ3l5MkpmaWpLaDFpTWlhMmVBNi1yTG9id1BpbGtOZUJJbEZaRlFsNE16T0xSeTRjUHkwN3p0Sjl1dzVVM1lzTzBrcHNOUFRKZDdKNzhPSjdoVQ?oc=5","date":"2025-06-13","type":"deal","source":"AstraZeneca","summary":"AstraZeneca enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research - AstraZeneca","headline":"AstraZeneca enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNamVYY0xkU3RNQmZpbHdUU28wSWw0Uk56ZUpFMUNYc1FINmRxcDVNczJtQ1BqR0VGRmJndGdmanBvYV9jN3BONUg5THZNUkx6aWlBQk1zd1VkUVVMdHM4OUIyZ3gzWFg5c0hubUdxaDg2U013U0lhb2NZZ2w2cUQyd0RwWldrMXpmdEVZMmVxeEZOZ0dvaUNxM1pIc3J5Sk1YeXNzM2lOSXdmc3QzTXd2UklXRQ?oc=5","date":"2025-06-02","type":"deal","source":"Pharmaceutical Executive","summary":"Roundup: Pharma Giants Expand Strategic Pipelines Through Targeted M&A and Partnerships - Pharmaceutical Executive","headline":"Roundup: Pharma Giants Expand Strategic Pipelines Through Targeted M&A and Partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNQlNtR0FBMGV1SldSdXR4OGs4RnNjZjR0QS1Zd2NQREd2X3o1cTA4S3pZNk1CdEdfbUM4VU9hWlNwaDJESDJwdGtUUUhOZXRTeS1wc3lJeHZFc2V1V3VlNkJMTmVOR0o2MG1fakJsQi1LamdGSk51ckVmZ3ZLd2tpNTlvVQ?oc=5","date":"2025-05-28","type":"deal","source":"Pharmaceutical Technology","summary":"Biogen and City Therapeutics to partner on RNAi therapies - Pharmaceutical Technology","headline":"Biogen and City Therapeutics to partner on RNAi therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9jbXpUT3N6LUl2QTJaZHk5QXJvMGZ2NWRPU001VkFPbmlUTXVWbUxNRS03T0VRYW9UZ0dkLU5aVWdGeEI4cW5xTnpIRG5QUHA3MS1j?oc=5","date":"2025-05-27","type":"pipeline","source":"FirstWord Pharma","summary":"Biogen taps City Therapeutics tech for RNAi therapies - FirstWord Pharma","headline":"Biogen taps City Therapeutics tech for RNAi therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOMVhJTFk4SDlUYmxPNU0yZ2Vld3FrYkxxMU93bHZiNEJRM3VINlp6UlNLd3dJZUZfMzlhLVZuTzF0T1kwZTBLWUtOWThoMzlQWUUzQTFxUTUwajhSNG5ISl96dDVJdnhVdENSb1pXQTFvZkpHNk9zZUF6NkJwaS1jeXVBUDBseHptMlhvNDQydi1OYUw4ZTJxTEdMb0NMVE9xR1dsSFFGaVhqTUVGZlBfSlhwazhzdHJwVWp6WS0xbnVZb0JFRlcyZFBxX3djYy00WlBBMmIxc9IB3AFBVV95cUxQVE5KSWxyUy1XcldiTzY2Z2J1Z2dJQ0VLS3V0ZHhNMXhCX2RQaXZFbVFUREIwM0RHR3VudDI0NkQ5SnhTdUpsOWVrZzNFR0haX05wU3ZrQXEtUF9fWXR2OUkzd0ZfdjViMVR5SGJncjhna3pULTR6VHhLSXdfVjh4S2Q0aUlRUktyUEpQbjZxd2hoVVRzTVhRX3FuS05qODZMS0dKUHM1bElWY05YeDlqUG1JVTh6R2hnT0FkOFV6M05zUFRzUmItdzNDUFFRcWJ0SFYxSWcyQ3RPV05C?oc=5","date":"2025-05-27","type":"deal","source":"simplywall.st","summary":"Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal - simplywall.st","headline":"Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQYnRmNl9OUzVzVnNtNHB2djgybU9GYUxUWVlacVppUEhjdWc0dHdLR2VPUVhpbzcxX3U5bXZRZEZVbU10anNCWTRiM3EtTnVCN1FBUC01N2pFOXB6TWJBcEwxLU5UZ2JJQUUtOXpLS1QzNFN4U1JnN0JoMjFULXk0SFZaNnlWaFF3cGx1Q25SZXN1RlMzOEtXYV9GcGlRZEhGekRVRVpTYzBJMDg?oc=5","date":"2025-05-13","type":"deal","source":"Fierce Pharma","summary":"Ratio inks deal to build radiopharmaceutical R&D, manufacturing facility in Utah - Fierce Pharma","headline":"Ratio inks deal to build radiopharmaceutical R&D, manufacturing facility in Utah","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPaVZNUmlla3lFb3Q0MVZDWlBvYXJQcXdJZkdlSVg4MnE4dEVyekQxTUVwWXg0WktrT1hQUVVlN1loUHdNVHFzT24yeXFZUTRlRTNOSk41ZTllenlJYUc0M1lRS0JnRjZqaGdaRWNISkowLXBhb3pyTWszNkJpTkg2bU1ZbjMya0dKVm9vcnVJOGphdl85R0JSUXRn?oc=5","date":"2024-10-08","type":"pipeline","source":"BioPharma Dive","summary":"Startup led by John Maraganore raises $135M to build ‘future of RNAi’ - BioPharma Dive","headline":"Startup led by John Maraganore raises $135M to build ‘future of RNAi’","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}